Skip to main content

Advertisement

Log in

Heterozygote genotypes for PADI4_89 were protectively associated with susceptibility to tuberculosis in Koreans

  • Short Communication - Genes and Disease
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

The aim of this study was to determine whether peptidyl arginine deiminase (PADI) genes could affect susceptibility to tuberculosis (TB), which can be a presumptive base to explain the increased incidence of TB in patients with rheumatoid arthritis (RA) in Korean. The study population consisted of 47 patients with active TB, 35 patients with nontuberculous mycobacterial disease, 50 RA patients, and 83 healthy controls who had received comprehensive medical testing. Genomic DNA was isolated from peripheral blood mononuclear cells using a standard protocol. All of the patients and healthy controls were genotyped for two nonsynonymous SNPs in PADI4, namely PADI4_89, PADI4_90, and one synonymous SNP in PADI4_104. There was the complete linkage between PADI4_89 and PADI4_90 SNPs. In the allele and haplotype analyses of PADI4_89 and PADI4_104, no significant associations are observed between disease groups and control groups. The frequencies of heterozygote (A/G) for PADI4_89 were significantly lower in patients with active TB than in controls [adjusted odd ratios (OR) = 0.35, p values = 0.020]. When the analysis was conducted by overdominant model, more significant associations are observed (adjusted OR = 0.34, p values = 0.005). We found that heterozygote genotypes for PADI4_89 were protectively associated with susceptibility to TB.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Baronnet L, Barnetche T, Kahn V, Lacoin C, Richez C, Schaeverbeke T (2011) Incidence of tuberculosis in patients with rheumatoid arthritis. A systematic literature review. Joint Bone Spine 78(3):279–284

    Article  PubMed  Google Scholar 

  2. Dixon WG, Hyrich KL, Watson KD, Lunt M, Galloway J, Ustianowski A, Symmons DP (2010) Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR). Ann Rheum Dis 69(3):522–528

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  3. Cantini F, Niccoli L, Goletti D (2014) Tuberculosis risk in patients treated with non-anti-tumor necrosis factor-alpha (TNF-alpha) targeted biologics and recently licensed TNF-alpha inhibitors: data from clinical trials and national registries. J Rheumatol Suppl 91:56–64

    Article  CAS  PubMed  Google Scholar 

  4. Singh JA, Wells GA, Christensen R, Tanjong Ghogomu E, Maxwell L, Macdonald JK, Filippini G, Skoetz N, Francis D, Lopes LC, Guyatt GH, Schmitt J, La Mantia L, Weberschock T, Roos JF, Siebert H, Hershan S, Lunn MP, Tugwell P, Buchbinder R (2011) Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev 2:CD008794

    PubMed  Google Scholar 

  5. Seong SS, Choi CB, Woo JH, Bae KW, Joung CL, Uhm WS, Kim TH, Jun JB, Yoo DH, Lee JT, Bae SC (2007) Incidence of tuberculosis in Korean patients with rheumatoid arthritis (RA): effects of RA itself and of tumor necrosis factor blockers. J Rheumatol 34(4):706–711

    CAS  PubMed  Google Scholar 

  6. Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Coster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapaa-Dahlqvist S, Saxne T, Romanus V, Klareskog L, Feltelius N (2005) Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden. Arthritis Rheum 52(7):1986–1992

    Article  CAS  PubMed  Google Scholar 

  7. Acevedo-Vasquez E, Ponce de Leon D, Gamboa-Cardenas R (2009) Latent infection and tuberculosis disease in rheumatoid arthritis patients. Rheum Dis Clin N Am 35(1):163–181

    Article  Google Scholar 

  8. Yamada T, Nakajima A, Inoue E, Tanaka E, Hara M, Tomatsu T, Kamatani N, Yamanaka H (2006) Increased risk of tuberculosis in patients with rheumatoid arthritis in Japan. Ann Rheum Dis 65(12):1661–1663

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Carmona L, Hernandez-Garcia C, Vadillo C, Pato E, Balsa A, Gonzalez-Alvaro I, Belmonte MA, Tena X, Sanmarti R (2003) Increased risk of tuberculosis in patients with rheumatoid arthritis. J Rheumatol 30(7):1436–1439

    PubMed  Google Scholar 

  10. Repasy T, Lee J, Marino S, Martinez N, Kirschner DE, Hendricks G, Baker S, Wilson AA, Kotton DN, Kornfeld H (2013) Intracellular bacillary burden reflects a burst size for Mycobacterium tuberculosis in vivo. PLoS Pathog 9(2):e1003190

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  11. Ramos-Kichik V, Mondragon-Flores R, Mondragon-Castelan M, Gonzalez-Pozos S, Muniz-Hernandez S, Rojas-Espinosa O, Chacon-Salinas R, Estrada-Parra S, Estrada-Garcia I (2009) Neutrophil extracellular traps are induced by Mycobacterium tuberculosis. Tuberculosis (Edinb) 89(1):29–37

    Article  Google Scholar 

  12. Seiler P, Aichele P, Bandermann S, Hauser AE, Lu B, Gerard NP, Gerard C, Ehlers S, Mollenkopf HJ, Kaufmann SH (2003) Early granuloma formation after aerosol Mycobacterium tuberculosis infection is regulated by neutrophils via CXCR3-signaling chemokines. Eur J Immunol 33(10):2676–2686

    Article  CAS  PubMed  Google Scholar 

  13. Braian C, Hogea V, Stendahl O (2013) Mycobacterium tuberculosis-induced neutrophil extracellular traps activate human macrophages. J Innate Immun 5(6):591–602

    Article  CAS  PubMed  Google Scholar 

  14. Chang X, Han J, Pang L, Zhao Y, Yang Y, Shen Z (2009) Increased PADI4 expression in blood and tissues of patients with malignant tumors. BMC Cancer 9:40

    Article  PubMed Central  PubMed  Google Scholar 

  15. (1997) Diagnosis and treatment of disease caused by nontuberculous mycobacteria. This official statement of the American Thoracic Society was approved by the Board of Directors, March 1997. Medical Section of the American Lung Association. Am J Respir Crit Care Med 156(2 Pt 2):S1–S25

  16. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315–324

    Article  CAS  PubMed  Google Scholar 

  17. Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC (2006) A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum 54(1):90–96

    Article  CAS  PubMed  Google Scholar 

  18. Hraber P, Kuiken C, Yusim K (2007) Evidence for human leukocyte antigen heterozygote advantage against hepatitis C virus infection. Hepatology 46(6):1713–1721

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant of the Korea Health 21 R&D Project by the Ministry of Health and Welfare (01-PJ3-PG6-01GN09-003), EMBRI Grants 2010-EMBRI DJ 0002 from the Eulji University, and of the Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea (A102065).

Conflict of interest

No potential conflicts of interest were disclosed.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Dong-Hyuk Sheen or Seung-Cheol Shim.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lim, MK., Shim, T.S., Park, M. et al. Heterozygote genotypes for PADI4_89 were protectively associated with susceptibility to tuberculosis in Koreans. Rheumatol Int 35, 651–655 (2015). https://doi.org/10.1007/s00296-014-3119-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-014-3119-7

Keywords

Navigation